GSK-HMA112795

Study Sponsor: GSK

Study Title

A two part, multicenter Phase IIa, placebo controlled study, to examine the safety, tolerability, and effects of GSK256073 on lipids in subjects with dyslipidemia

Medicine or Vaccine (generic name)

GSK256073

Sponsor Identification Number

HMA112795

Trial Registry Identification Number(#'s)

NCT00903617

Medical Condition

Dyslipidaemias

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=112795

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00903617

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

September 2019